Hemangioma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 17: | Line 17: | ||
:::*Periorbital lesions | :::*Periorbital lesions | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 19:54, 17 November 2015
|
Hemangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemangioma medical therapy On the Web |
|
American Roentgen Ray Society Images of Hemangioma medical therapy |
|
Risk calculators and risk factors for Hemangioma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Medical Therapy
- Medical and surgical options are available for the treatment of “problematic” hemangiomas.[1]
- Medical management includes one or more systemic therapies.
- For massive and life-threatening disease:[1]
-
- These agents have also been used for:
- Multifocal disease
- Visceral involvement
- Segmental distribution
- Airway obstruction
- Periorbital lesions